ATE263561T1 - Thiazolylbenzofuranderivate und ihre verwendung als srs-a- und leukotrien-antagonisten - Google Patents
Thiazolylbenzofuranderivate und ihre verwendung als srs-a- und leukotrien-antagonistenInfo
- Publication number
- ATE263561T1 ATE263561T1 AT01123263T AT01123263T ATE263561T1 AT E263561 T1 ATE263561 T1 AT E263561T1 AT 01123263 T AT01123263 T AT 01123263T AT 01123263 T AT01123263 T AT 01123263T AT E263561 T1 ATE263561 T1 AT E263561T1
- Authority
- AT
- Austria
- Prior art keywords
- srs
- antagonists
- leucotrien
- thiazolylbenzofuran
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9601235.6A GB9601235D0 (en) | 1996-01-22 | 1996-01-22 | Novel compounds |
AUPO1111A AUPO111196A0 (en) | 1996-07-18 | 1996-07-18 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE263561T1 true ATE263561T1 (de) | 2004-04-15 |
Family
ID=25645218
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97900432T ATE216384T1 (de) | 1996-01-22 | 1997-01-17 | Thiazolylbenzofuranderivate und pharmazeutische zusammensetzungen die sie enthalten |
AT01123263T ATE263561T1 (de) | 1996-01-22 | 1997-01-17 | Thiazolylbenzofuranderivate und ihre verwendung als srs-a- und leukotrien-antagonisten |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97900432T ATE216384T1 (de) | 1996-01-22 | 1997-01-17 | Thiazolylbenzofuranderivate und pharmazeutische zusammensetzungen die sie enthalten |
Country Status (12)
Country | Link |
---|---|
US (1) | US5994378A (de) |
EP (2) | EP0880519B1 (de) |
JP (1) | JP2000503984A (de) |
KR (1) | KR19990076788A (de) |
CN (1) | CN1209809A (de) |
AT (2) | ATE216384T1 (de) |
CA (1) | CA2244189A1 (de) |
DE (2) | DE69728581D1 (de) |
EA (1) | EA199800650A1 (de) |
ES (1) | ES2171878T3 (de) |
HU (1) | HUP9900424A2 (de) |
WO (1) | WO1997027190A1 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9919413D0 (en) * | 1999-08-18 | 1999-10-20 | Zeneca Ltd | Chemical compounds |
WO2001032621A1 (fr) * | 1999-10-29 | 2001-05-10 | Wakunaga Pharmaceutical Co., Ltd. | Nouveaux derives d'indole, et medicaments contenant lesdits derives comme principe actif |
KR100863659B1 (ko) * | 2001-04-16 | 2008-10-15 | 미쓰비시 타나베 파마 코퍼레이션 | 질소-함유 헤테로시클릭 화합물 및 이를 포함하는 제약 조성물 |
CN1330641C (zh) | 2001-08-10 | 2007-08-08 | 日本化学医药株式会社 | 过氧化物酶体增殖剂响应受体δ活化剂 |
MXPA04003398A (es) | 2001-10-12 | 2004-11-22 | Nippon Chemiphar Co | Activador para el receptor o activado con el proliferador de peroxisoma. |
WO2006019831A1 (en) * | 2004-07-14 | 2006-02-23 | Ptc Therapeutics, Inc. | Methods for treating hepatitis c |
ATE499344T1 (de) * | 2004-10-12 | 2011-03-15 | Decode Genetics Ehf | Peri-substituierte bicyclische sulfonamide gegen arterielle verschlusskrankheit |
WO2006046683A1 (en) * | 2004-10-25 | 2006-05-04 | Astellas Pharma Inc. | Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
GB2431927B (en) * | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
EP1984334B1 (de) * | 2006-02-15 | 2014-04-09 | Allergan, Inc. | Indol-3-carbonsäureamid-, ester-, thioamid- und thiolesterverbindungen mit aryl- oder heteroarylgruppen mit biologischer sphingosin-1-phosphat (s1p)-rezeptorantagonistenwirkung |
CN101460458A (zh) * | 2006-02-15 | 2009-06-17 | 阿勒根公司 | 具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物 |
CN102643248A (zh) | 2006-04-18 | 2012-08-22 | 日本化学医药株式会社 | 过氧化物酶体增殖剂激活受体δ的激活剂 |
DE102006021733A1 (de) * | 2006-05-09 | 2007-11-22 | Bayer Healthcare Ag | 3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung |
CN101490045A (zh) * | 2006-05-16 | 2009-07-22 | 解码遗传Ehf公司 | 7-(丙烯酰基)吲哚的制备方法 |
DE102006043443A1 (de) * | 2006-09-15 | 2008-03-27 | Bayer Healthcare Ag | Neue aza-bicyclische Verbindungen und ihre Verwendung |
JP2010515750A (ja) * | 2007-01-11 | 2010-05-13 | アラーガン インコーポレイテッド | スフィンゴシン−1−ホスフェート(s1p)受容体アンタゴニスト生物活性を有する6−置換インドール−3−カルボン酸アミド化合物 |
US8524917B2 (en) | 2007-01-11 | 2013-09-03 | Allergan, Inc. | 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
CN104672220B (zh) | 2008-04-15 | 2017-09-22 | 日本化学医药株式会社 | 过氧化物酶体增殖剂活化受体的活化剂 |
DE102008063992A1 (de) | 2008-12-19 | 2010-09-02 | Lerner, Zinoviy, Dipl.-Ing. | Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung |
ES2742195T3 (es) | 2010-03-12 | 2020-02-13 | Omeros Corp | Inhibidores de PDE10 y composiciones y métodos relacionados |
EP2655362A1 (de) | 2010-12-22 | 2013-10-30 | Abbvie Inc. | Hepatitis-c-inhibitoren und ihre verwendung |
SG11201506211RA (en) | 2013-02-21 | 2015-09-29 | Adverio Pharma Gmbh | Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate |
NZ630803A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Optically active pde10 inhibitor |
NZ630810A (en) | 2014-04-28 | 2016-03-31 | Omeros Corp | Processes and intermediates for the preparation of a pde10 inhibitor |
HRP20211778T1 (hr) | 2014-08-29 | 2022-03-18 | Chdi Foundation, Inc. | Kontrastna sredstva za slikovnu dijagnostiku huntingtin proteina |
CN107530313A (zh) | 2015-04-24 | 2018-01-02 | 奥默罗斯公司 | Pde10抑制剂以及相关组合物和方法 |
CA3003611C (en) | 2015-11-04 | 2022-11-01 | Omeros Corporation | Solid state forms of a pde10 inhibitor |
CA3081553C (en) | 2017-11-17 | 2022-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of eye disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2600644B2 (ja) * | 1991-08-16 | 1997-04-16 | 藤沢薬品工業株式会社 | チアゾリルベンゾフラン誘導体 |
JPH07179856A (ja) * | 1993-12-21 | 1995-07-18 | Canon Inc | 液晶性化合物、これを含有する液晶組成物、該液晶組成物を用いた液晶素子並びにこれらを用いた表示方法、表示装置 |
-
1997
- 1997-01-17 ES ES97900432T patent/ES2171878T3/es not_active Expired - Lifetime
- 1997-01-17 WO PCT/JP1997/000073 patent/WO1997027190A1/en not_active Application Discontinuation
- 1997-01-17 DE DE69728581T patent/DE69728581D1/de not_active Expired - Lifetime
- 1997-01-17 DE DE69712042T patent/DE69712042T2/de not_active Expired - Fee Related
- 1997-01-17 KR KR1019980704913A patent/KR19990076788A/ko not_active Application Discontinuation
- 1997-01-17 US US09/101,766 patent/US5994378A/en not_active Expired - Fee Related
- 1997-01-17 EA EA199800650A patent/EA199800650A1/ru unknown
- 1997-01-17 EP EP97900432A patent/EP0880519B1/de not_active Expired - Lifetime
- 1997-01-17 JP JP9526720A patent/JP2000503984A/ja not_active Ceased
- 1997-01-17 AT AT97900432T patent/ATE216384T1/de not_active IP Right Cessation
- 1997-01-17 CA CA002244189A patent/CA2244189A1/en not_active Abandoned
- 1997-01-17 EP EP01123263A patent/EP1170009B1/de not_active Expired - Lifetime
- 1997-01-17 CN CN97191798A patent/CN1209809A/zh active Pending
- 1997-01-17 HU HU9900424A patent/HUP9900424A2/hu unknown
- 1997-01-17 AT AT01123263T patent/ATE263561T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1209809A (zh) | 1999-03-03 |
US5994378A (en) | 1999-11-30 |
WO1997027190A1 (en) | 1997-07-31 |
ES2171878T3 (es) | 2002-09-16 |
HUP9900424A2 (hu) | 1999-05-28 |
CA2244189A1 (en) | 1997-07-31 |
KR19990076788A (ko) | 1999-10-15 |
DE69712042D1 (de) | 2002-05-23 |
ATE216384T1 (de) | 2002-05-15 |
EP0880519A1 (de) | 1998-12-02 |
EP1170009B1 (de) | 2004-04-07 |
EA199800650A1 (ru) | 1999-02-25 |
EP1170009A3 (de) | 2002-01-16 |
DE69712042T2 (de) | 2002-10-02 |
JP2000503984A (ja) | 2000-04-04 |
DE69728581D1 (de) | 2004-05-13 |
EP1170009A2 (de) | 2002-01-09 |
EP0880519B1 (de) | 2002-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE263561T1 (de) | Thiazolylbenzofuranderivate und ihre verwendung als srs-a- und leukotrien-antagonisten | |
DE69910831D1 (de) | Epothilonderivate und ihre verwendung als antitumormittel | |
DE69328975D1 (de) | Aminomethylen substituierte heterocyclische verbindungen und ihre verwendung alssubstanz p antagonisten | |
DE69721008T2 (de) | Bicyclische pyrimidine derivate und ihre verwendung als antikoagulantien | |
ES2111617T3 (es) | Derivados de pirimidina condensados y su utilizacion como antagonistas de la angiotensina ii. | |
FI902555A0 (fi) | Diarylstyrylkinolindisyror. | |
ATE181056T1 (de) | Arylessigsäurederivate und ihre verwendung als fungizide | |
DE50201565D1 (de) | 2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie | |
CY1108837T1 (el) | ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5 | |
MX9306666A (es) | Nuevas azetidinonas substituidas como agentes antiinflamatorios y antidegenerativos. | |
DE69922009D1 (de) | Imidazolverbindungen und ihre verwendung als adenosindeaminase-inhibitoren | |
TR199902807A2 (xx) | 2-(tio ikameli)tiazolo-$4,5-b]piridin bile�iklerinin pestisit ve parasitisel kullan�m�. | |
DE69504198T2 (de) | Substituierte alkyldiaminderivate und ihre verwendung als tachykinin antagonisten | |
NO895165D0 (no) | Pyrazolopyridin-type mevalono-laktoner. | |
FI963645A0 (fi) | Silmänpainetta alentava aine | |
DE59605148D1 (de) | Dithiazoldioxide und ihre verwendung als mikrobizide | |
ATE340175T1 (de) | Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |